Wu, C.-K.; Su, M.-Y.M.; Wu, Y.-F.; Hwang, J.-J.; Lin, L.-Y.
Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients. J. Clin. Med. 2018, 7, 427.
https://doi.org/10.3390/jcm7110427
AMA Style
Wu C-K, Su M-YM, Wu Y-F, Hwang J-J, Lin L-Y.
Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients. Journal of Clinical Medicine. 2018; 7(11):427.
https://doi.org/10.3390/jcm7110427
Chicago/Turabian Style
Wu, Cho-Kai, Mao-Yuan M. Su, Yi-Fan Wu, Juey-Jen Hwang, and Lian-Yu Lin.
2018. "Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients" Journal of Clinical Medicine 7, no. 11: 427.
https://doi.org/10.3390/jcm7110427
APA Style
Wu, C.-K., Su, M.-Y. M., Wu, Y.-F., Hwang, J.-J., & Lin, L.-Y.
(2018). Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients. Journal of Clinical Medicine, 7(11), 427.
https://doi.org/10.3390/jcm7110427